Zacks.com Announces That Richard Rhodes Highlights the Following Stocks: Citigroup, Marsh & McLennan, Kerr-McGee, Barr Pharma, and KLA-Tencor.CHICAGO -- Richard Rhodes Richard Lee Rhodes (b. July 4, 1937) is an American journalist, historian, and author of both fiction and non-fiction (which he prefers to call "verity"), including the Pulitzer Prize-winning The Making of the Atomic Bomb (1986), and most recently, isn't ready to offer a broad bearish Bearish Words used to describe investor attitude. A bearish investor believes that a particular asset or the market as a whole will decline in value. bearish program, but has instead decided to lean toward long positions. Find out why this expert's perspective is neutral right now, and learn about some of his trading positions and stocks to watch. Read about Citigroup (NYSE NYSE See: New York Stock Exchange :C), Marsh & McLennan (NYSE:MMC See MultiMediaCard and Microsoft Management Console. ), Kerr-McGee Corporation (NYSE:KMG KMG Kerr-McGee KMG Koi Mil Gaya (Hindi movie) KMG Kunming, China - Kunming (Airport Code) KMG Kent Messenger Group (UK) ), Barr Pharmaceuticals Barr Pharmaceuticals, Inc., (NYSE: [http://www.nyse.com/about/listed/lcddata.html?ticker=BRL BRL]) is global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and , Inc. (NYSE:BRL BRL In currencies, this is the abbreviation for the Brazilian Real. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. ), and KLA-Tencor Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :KLAC). Richard Rhodes is editor of The Rhodes Report newsletter. Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84 Here are the highlights from the Featured Expert column: Richard Rhodes' perspective at this point is rather neutral, with a short-term bias towards long positions, while the longer-term structural issues keep him on his bearish toes. That said, Rhodes and team cannot see a large decline develop without the financial sector, which at this point continues to outperform Outperform An analyst recommendation meaning a stock is expected to do slightly better than the market return. Notes: Exact definitions vary by brokerage, but in general this rating is better than neutral and worse than buy or strong buy. . The most important stock in that universe is Citigroup (NYSE:C) - which he is long; its shares continue to slowly, but surely rise in bullish fashion. Also, the corporate bond arena continues to become more and more optimistic op·ti·mist n. 1. One who usually expects a favorable outcome. 2. A believer in philosophical optimism. op concerning cash flow for corporate America - and as long as corporate bond investors are becoming 'more optimistic' - Rhodes has a very difficult time offering up a wide and broad bearish program. In the past...the corporate bond area has weakened prior to any large equity decline. And given that simply isn't the case right now...he must err upon the side of long positions with an eye towards the door. Trading Positions The shares below are issues in which Rhodes currently holds a position. Marsh & McLennan (NYSE:MMC) is primarily a holding company which, through its subsidiaries and affiliates, provides clients with analysis, advice and transactional capabilities in the fields of risk and insurance services, investment management and consulting. Kerr-McGee Corporation (NYSE:KMG) is engaged in two worldwide businesses: oil and gas exploration and production and the production and marketing of titanium dioxide pigment. StockWatch Waiting Room The shares below are issues in which Rhodes is interested in adding to the Trading Positions, but is "waiting" for further appropriate technical evidence in order to trade with a high degree of confidence. Long Candidates: Barr Pharmaceuticals, Inc. (NYSE:BRL) and its subsidiaries are engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals. KLA-Tencor Corporation (NASDAQ:KLAC) is one of the world's leading suppliers of process control and yield management solutions for the semiconductor and related microelectronics industries. Read Richard Rhodes' complete capital market commentary, along with all of his trading positions, by clicking: http://at.zacks.com/?id=85 About Zacks Featured Experts To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research Zacks Investment Research A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc. Recommendations from Featured Experts Highlighted in FREE Investment Newsletter The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail See Internet e-mail service. newsletter. Get your free subscription to "Profit from the Pros" at: http://at.zacks.com/?id=86 About Zacks Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit http://at.zacks.com/?id=87 Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation solicitation In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual to buy or sell any security. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion